AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) was started with a Buy rating and $17.00 price target at Jefferies.
Apple Inc. (NASDAQ: AAPL) was started with a Buy rating and a $650 price target at Deutsche Bank.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) was maintained as Neutral and the price target was cut to $70 from $78 at Credit Suisse. Bank of America Merrill Lynch cut the rating to Neutral from Buy. Argus maintained its Buy rating, but lowered its target to $80 from $85. Canaccord Genuity lowered its price target to $62 from $72.
DexCom Inc. (NASDAQ: DXCM) was raised to Buy from Neutral with a $50 price target at Sterne Agee.
EMC Corp. (NYSE: EMC) was started as Buy with a $32 price target at Deutsche Bank.
Facebook Inc. (NASDAQ: FB) was raised to Buy at a boutique firm named Pivotal Research.
ALSO READ: Warren Buffett’s Top Dividend Stocks
Hewlett-Packard Co. (NYSE: HPQ) was started as Buy with a $40 price target at Deutsche Bank.
Imperva Inc. (NYSE: IMPV) is getting crushed after its guidance disappointed. Oppenheimer downgraded the stock to Perform from Outperform.
International Business Machines Corp. (NYSE: IBM) was started as Hold with a mere $200 price target at Deutsche Bank.
ALSO READ: Another Panic Sell Rating Downgrade in Coal
NetApp Inc. (NASDAQ: NTAP) was started as Hold at Deutsche Bank.
Questar Corp. (NYSE: STR) was started with an Underperform rating and $22 price target (versus a $23.49 close) at Merrill Lynch.
Twitter Inc. (NYSE: TWTR) was raised to Hold from Sell with a $45 price target by Cantor Fitzgerald, a call based on valuation after the recent pullback.
ALSO READ: Eight Stocks Made Cheap After the Sell Off
UGI Corp. (NYSE: UGI) was started as Buy with a $53 price target (versus a $45.06 close) at Merrill Lynch.
WESCO International Inc. (NYSE: WCC) was raised to Buy from Neutral and the target was raised to $100 from $84 by UBS.
Top Gaining Stocks
Top Losing Stocks